Press Room

Joint Drug Agreement (JDA)

Major League Baseball's Joint Drug Prevention and Treatment Program

 

Major League Baseball's Joint Drug Prevention and Treatment Program (the "Program") was established by agreement of the Office of the Commissioner of Baseball and the Major League Baseball Players Association to: (i) educate Players on the risks associated with the use of Prohibited Substances; (ii) deter and end the use of Prohibitied Substances by Players; and (iii) provide for, in keeping with the overall purposes of the Program, an orderly, systematic, and cooperative resolution of any disputes that may arise concerning the existence, interpretation, or application of this Program.  Except as otherwise provided, any dispute arising under the Program shall be subject to resolution through the Grievance Procedure of the Basic Agreement.

The Program covers: (i) all Players on the Major League Clubs' 40-man rosters; (ii) any Player who becomes a free agent under Aritcle XIX or Articl XX of the Basic Agreement; and (iii) any Player who is released from a Major League roster unless the Player voluntarily retires or signs a Minor League contract with a club in an unaffiliated professional baseball league.